Table 2.

IVF/ICSI outcomes of half-dose depot GnRH-agonist and GnRH-antagonist protocols in which corifollitropin alfa was used

	Depot GnRH agonist+ corifollitropin alfa group (n=45)	GnRH antagonist+ corifollitropin alfa group (n=49)
Positive β-hCG	18 (40%)	18 (36.7%)	0.93
CPR	16 (35.6%)	16 (32.7)	0.95
BPR	2 (4.44%)	2 (4.08%)	NS
Implantation rate (%)	32.5±6.82	36.25±8.58	0.73
Singleton pregnancy rate	13/16 (81.25)	12/16 (75%)	NS
Twin pregnancy rate	3/16 (18.75%)	4/16 (25%)	NS
OHSS rate	0	0	NS
Cancel rate	5 (11.1%)	9 (18.4%)	0.46

CPR: clinical pregnancy rate; BPR: biochemical pregnancy rate; GnRH: gonadotropin hormone-releasing hormone; IVF/ICSI: in vitro fertilization/intracytoplasmic sperm injection; hCG: human chorionic gonadotropin; OHSS: ovarian hyperstimulation syndrome